The company had clocked a profit of Rs 6.85 crore in October-December FY23, according to a regulatory filing by the company now controlled by private equity firm Advent International.

Read More

​ The company had clocked a profit of Rs 6.85 crore in October-December FY23, according to a regulatory filing by the company now controlled by private equity firm Advent International. The company had clocked a profit of Rs 6.85 crore in October-December FY23, according to a regulatory filing by the company now controlled by private equity firm Advent International.  Moneycontrol Latest News Read More  

The company had clocked a profit of Rs 6.85 crore in October-December FY23, according to a regulatory filing by the company now controlled by private equity firm Advent International.

It had clocked a net profit of Rs 23 crore in the October-December period of FY23, the company said in an exchange filing.

Read More

​ It had clocked a net profit of Rs 23 crore in the October-December period of FY23, the company said in an exchange filing. It had clocked a net profit of Rs 23 crore in the October-December period of FY23, the company said in an exchange filing.  Moneycontrol Latest News Read More  

It had clocked a net profit of Rs 23 crore in the October-December period of FY23, the company said in an exchange filing.

NMDC Q3 results: The country’s largest iron ore producer#39;s profit rose 67% on a standalone basis.

Read More

​ NMDC Q3 results: The country’s largest iron ore producer#39;s profit rose 67% on a standalone basis. NMDC Q3 results: The country’s largest iron ore producer#39;s profit rose 67% on a standalone basis.  Moneycontrol Latest News Read More  

NMDC Q3 results: The country’s largest iron ore producer#39;s profit rose 67% on a standalone basis.

The drug firm had reported a PAT of Rs 232 crore in the year-ago period.

Read More

​ The drug firm had reported a PAT of Rs 232 crore in the year-ago period. The drug firm had reported a PAT of Rs 232 crore in the year-ago period.  Moneycontrol Latest News Read More  

The drug firm had reported a PAT of Rs 232 crore in the year-ago period.

The drug firm had reported a PAT of Rs 232 crore in the year-ago period.

Read More

​ The drug firm had reported a PAT of Rs 232 crore in the year-ago period. The drug firm had reported a PAT of Rs 232 crore in the year-ago period.  Moneycontrol Latest News Read More  

The drug firm had reported a PAT of Rs 232 crore in the year-ago period.

The drug firm had reported a PAT of Rs 232 crore in the year-ago period.

Read More

​ The drug firm had reported a PAT of Rs 232 crore in the year-ago period. The drug firm had reported a PAT of Rs 232 crore in the year-ago period.  Moneycontrol Latest News Read More  

The drug firm had reported a PAT of Rs 232 crore in the year-ago period.

The group said it expects a sales realisation of approximately Rs 7,500 crore from the project wherein the investment would be done via self-funding, bank financing and customer advances for bookings.

Read More

​ The group said it expects a sales realisation of approximately Rs 7,500 crore from the project wherein the investment would be done via self-funding, bank financing and customer advances for bookings. The group said it expects a sales realisation of approximately Rs 7,500 crore from the project wherein the investment would be done via self-funding, bank financing and customer advances for bookings.  Moneycontrol Latest News Read More  

The group said it expects a sales realisation of approximately Rs 7,500 crore from the project wherein the investment would be done via self-funding, bank financing and customer advances for bookings.

It had posted a net profit of Rs 9.74 crore in the October-December period of the preceding 2022-23 financial year, the company said in an exchange filing.

Read More

​ It had posted a net profit of Rs 9.74 crore in the October-December period of the preceding 2022-23 financial year, the company said in an exchange filing. It had posted a net profit of Rs 9.74 crore in the October-December period of the preceding 2022-23 financial year, the company said in an exchange filing.  Moneycontrol Latest News Read More  

It had posted a net profit of Rs 9.74 crore in the October-December period of the preceding 2022-23 financial year, the company said in an exchange filing.

It had clocked a net profit of Rs 903.89 crore in the year-ago period, the mining company said in an exchange filing.

Read More

​ It had clocked a net profit of Rs 903.89 crore in the year-ago period, the mining company said in an exchange filing. It had clocked a net profit of Rs 903.89 crore in the year-ago period, the mining company said in an exchange filing.  Moneycontrol Latest News Read More  

It had clocked a net profit of Rs 903.89 crore in the year-ago period, the mining company said in an exchange filing.

This would be the first meeting of the FSDC after the passage of the Rs 47.6 lakh crore Budget for 2024-25, focussing on capital expenditure with an outlay of Rs 11.11 lakh crore.

Read More

​ This would be the first meeting of the FSDC after the passage of the Rs 47.6 lakh crore Budget for 2024-25, focussing on capital expenditure with an outlay of Rs 11.11 lakh crore. This would be the first meeting of the FSDC after the passage of the Rs 47.6 lakh crore Budget for 2024-25, focussing on capital expenditure with an outlay of Rs 11.11 lakh crore.  Moneycontrol Latest News Read More  

This would be the first meeting of the FSDC after the passage of the Rs 47.6 lakh crore Budget for 2024-25, focussing on capital expenditure with an outlay of Rs 11.11 lakh crore.